Skip to main content
Equibles
POSC logo

POSC · Positron Corp

Track POSC — free

Use POSC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.80 -0.01 (-0.75%) At close · Sep 4
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors create substantial doubt about the Company’s ability to continue as a going concern within the twelve-month period subsequent to the date that these financial statements are issued. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$59.45M
Shares
32.85M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.80 Open$1.81 Day$1.78–1.81 52W close$1.31–2.56 Avg vol 30d19K Short int13K · 0.0% float · 1.0d Short vol21% DataJan 2020–Sep 2026 Filing10-Q · Aug 14

Up next

Latest filing: 10-Q
filed Aug 14, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$444,822
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-6.9%
Year over year
Operating margin
-2,275.1%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.9%
Year over year · more shares
Price change (1Y)
+15.9%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +0%
above
Price vs 50-day avg +5%
above
RSI (14) 56
neutral
MACD trend Positive
52-week position 39%
mid-range
Momentum
relative strength
Neutral
1-month return +7%
trailing
6-month return −8%
trailing
YTD return +8%
this year
Relative strength −23%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.04% of float · ▲ +187.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1 holders — 13F breadth
Squeeze score 34
low risk · 0–100
Fundamentals
Poor
Revenue growth −21%
Y/Y
Gross margin -458%
contracting
EPS growth −278%
Y/Y
Free cash flow $-4.7M
Quant / Vol
risk profile
Very High
Volatility 96%
annualized · 1-yr
Max drawdown −40%
past year
ATR 5.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+0% Bullish
Price vs 50-day avg
+5% Bullish
RSI (14)
56 Neutral
MACD trend
Positive Bullish
52-week position
39% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow Accumulating
+1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.04% of float · ▲ +187.4% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
1 holders — 13F breadth
Price context
position in its 52-week range
Range low $1 Now $2 · 39% Range high $3
vs 200-day avg +0% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
POSC
Positron Corp
this stock
$59.45M +7.6% -21.5% — 0.0%
ABT
Abbott Laboratories
 $189.18B -13.5% +5.7% 30.4 1.2%
MDT
Medtronic plc
 $118.37B -2.0% +8.4% 22.8 1.1%
SYK
Stryker Corp
 $118.14B -13.8% +11.2% 31.9 1.8%
BSX
Boston Scientific Corp
 $70.10B -49.9% +12.5% 19.6 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1
% held
0.0%
Net QoQ
+50 sh
Top holder
Steward Partners Investme…
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
12.8K
Days to cover
1.0d
Change
+8.4K sh
View
Short Volume
Short vol %
21%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
979
Value
$1.8K
As of
Aug 13, 2026
View
Off-Exchange
Off-exchange %
99.7%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$461.5K
Net income (FY)
$-10.6M
EPS diluted
$-0.34
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 18, 2026
This year
4
View

Performance

5D 20D 120D MTD YTD
POSC +6.3% +6.6% -8.4% +10.2% +7.6%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +6.2% +7.0% -23.5% +9.8% -5.4%
Key facts CIK 844985 CUSIP 737397604 Visit website Investor relations